| |
| |
|
| Insider
Information: |
Conroy Kevin T |
| Relationship: |
|
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,204,819 |
|
|
Indirect Shares
|
238,579 |
|
|
| Direct
Value |
$52,122,028 |
|
|
|
Indirect Value
|
$10,693,111 |
|
|
| Total
Shares |
1,443,398 |
|
|
| Total
Value |
$62,815,138 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
|
2024-05-01 |
1,156,191 |
2024-05-01 |
238,579 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2018-07-02 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2023-03-06 |
22,968 |
2021-02-14 |
0 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director |
2021-09-01 |
25,000 |
2021-09-01 |
0 |
Premium* |
|
|
Align Technology Inc |
ALGN |
|
2024-05-22 |
660 |
2024-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
196 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2010-11-23 |
4 |
B |
$5.62 |
$33,720 |
D/D |
6,000 |
42,639 |
2.81 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-12-31 |
4 |
A |
$2.50 |
$15,000 |
D/D |
6,000 |
30,077 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-27 |
4 |
AS |
$56.89 |
$356,302 |
D/D |
(6,263) |
1,289,624 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,407 |
670,787 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,689 |
8,193 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2016-02-23 |
4 |
AS |
$6.39 |
$43,874 |
D/D |
(6,866) |
625,302 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2016-02-26 |
4 |
AS |
$5.81 |
$40,060 |
D/D |
(6,895) |
637,907 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2017-02-24 |
4 |
AS |
$21.57 |
$163,436 |
D/D |
(7,577) |
784,930 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-07-01 |
4 |
AS |
$123.43 |
$960,779 |
D/D |
(7,784) |
737,328 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,060 |
19,342 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-03-01 |
4 |
AS |
$59.32 |
$490,636 |
D/D |
(8,271) |
1,299,496 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2015-02-26 |
4 |
AS |
$23.44 |
$197,482 |
D/D |
(8,425) |
243,866 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2014-02-24 |
4 |
AS |
$14.07 |
$122,522 |
D/D |
(8,708) |
134,374 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
52,114 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2019-02-27 |
4 |
AS |
$95.07 |
$871,734 |
D/D |
(9,169) |
914,792 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2017-08-17 |
4 |
OE |
$10.82 |
$99,998 |
D/D |
9,242 |
830,052 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,312 |
819,677 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2015-01-02 |
4 |
AS |
$26.72 |
$253,412 |
D/D |
(9,484) |
223,214 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,705 |
1,177,632 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2020-02-28 |
4 |
AS |
$80.17 |
$781,658 |
D/D |
(9,750) |
992,963 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-03-02 |
4 |
AS |
$138.42 |
$1,355,962 |
D/D |
(9,796) |
799,163 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2015-02-24 |
4 |
AS |
$22.90 |
$224,374 |
D/D |
(9,798) |
232,791 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2019-02-28 |
4 |
AS |
$93.20 |
$933,345 |
D/D |
(10,014) |
925,353 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-06-30 |
4 |
A |
$1.47 |
$15,000 |
D/D |
10,204 |
62,318 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2022-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,373 |
889,067 |
0 |
- |
|
196 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
